Suppr超能文献

蔓越莓用于易感人群泌尿道感染的辅助治疗:一项系统评价和荟萃分析,采用试验序贯分析。

Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis.

机构信息

Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, P.R. China.

Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing, P.R. China.

出版信息

PLoS One. 2021 Sep 2;16(9):e0256992. doi: 10.1371/journal.pone.0256992. eCollection 2021.

Abstract

The efficacy of cranberry (Vaccinium spp.) as adjuvant therapy in preventing urinary tract infections (UTIs) remains controversial. This study aims to update and determine cranberry effects as adjuvant therapy on the recurrence rate of UTIs in susceptible groups. According to PRISMA guidelines, we conducted a literature search in Web of Science, PubMed, Embase, Scopus, and the Cochrane Library from their inception dates to June 2021. We included articles with data on the incidence of UTIs in susceptible populations using cranberry-containing products. We then conducted a trial sequential analysis to control the risk of type I and type II errors. This meta-analysis included 23 trials with 3979 participants. We found that cranberry-based products intake can significantly reduce the incidence of UTIs in susceptible populations (risk ratio (RR) = 0.70; 95% confidence interval(CI): 0.59 ~ 0.83; P<0.01). We identified a relative risk reduction of 32%, 45% and 51% in women with recurrent UTIs (RR = 0.68; 95% CI: 0.56 ~ 0.81), children (RR = 0.55; 95% CI: 0.31 ~ 0.97) and patients using indwelling catheters (RR = 0.49; 95% CI: 0.33 ~ 0.73). Meanwhile, a relative risk reduction of 35% in people who use cranberry juice compared with those who use cranberry capsule or tablet was observed in the subgroup analysis (RR = 0.65; 95% CI: 0.54 ~ 0.77). The TSA result for the effects of cranberry intake and the decreased risk of UTIs in susceptible groups indicated that the effects were conclusive. In conclusion, our meta-analysis demonstrates that cranberry supplementation significantly reduced the risk of developing UTIs in susceptible populations. Cranberry can be considered as adjuvant therapy for preventing UTIs in susceptible populations. However, given the limitations of the included studies in this meta-analysis, the conclusion should be interpreted with caution.

摘要

蔓越莓(Vaccinium spp.)作为辅助疗法预防尿路感染(UTIs)的疗效仍存在争议。本研究旨在更新并确定蔓越莓作为辅助疗法对易感人群 UTI 复发率的影响。根据 PRISMA 指南,我们在 Web of Science、PubMed、Embase、Scopus 和 Cochrane Library 中进行了文献检索,检索时间从建库开始到 2021 年 6 月。我们纳入了使用含蔓越莓产品的易感人群 UTI 发生率数据的研究。然后,我们进行了试验序贯分析以控制 I 型和 II 型错误的风险。这项荟萃分析纳入了 23 项试验,共 3979 名参与者。我们发现,蔓越莓产品的摄入可以显著降低易感人群 UTI 的发生率(风险比(RR)=0.70;95%置信区间(CI):0.590.83;P<0.01)。我们发现,在复发性 UTI 女性(RR=0.68;95%CI:0.560.81)、儿童(RR=0.55;95%CI:0.310.97)和留置导尿管患者(RR=0.49;95%CI:0.330.73)中,相对风险降低了 32%、45%和 51%。同时,在亚组分析中,与使用蔓越莓胶囊或片剂相比,使用蔓越莓汁的人群 UTI 风险降低了 35%(RR=0.65;95%CI:0.54~0.77)。TSA 分析蔓越莓摄入对易感人群 UTI 风险降低的结果表明,该结果具有结论性。总之,我们的荟萃分析表明,蔓越莓补充剂可显著降低易感人群发生 UTI 的风险。蔓越莓可以被认为是预防易感人群 UTI 的辅助治疗方法。然而,考虑到本荟萃分析纳入研究的局限性,应谨慎解释结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d511/8412316/554fb87aea80/pone.0256992.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验